Senhwa Biosciences Statistics
Total Valuation
Senhwa Biosciences has a market cap or net worth of TWD 4.18 billion. The enterprise value is 3.04 billion.
Market Cap | 4.18B |
Enterprise Value | 3.04B |
Important Dates
The next estimated earnings date is Friday, November 8, 2024.
Earnings Date | Nov 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Senhwa Biosciences has 89.19 million shares outstanding.
Shares Outstanding | 89.19M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 3.34% |
Owned by Institutions (%) | 0.10% |
Float | 67.13M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 4,183.02 |
PB Ratio | 3.52 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -10.41 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -10.76 |
Financial Position
The company has a current ratio of 48.44, with a Debt / Equity ratio of 1.65.
Current Ratio | 48.44 |
Quick Ratio | 48.13 |
Debt / Equity | 1.65 |
Debt / EBITDA | n/a |
Debt / FCF | -0.07 |
Interest Coverage | -531.65 |
Financial Efficiency
Return on equity (ROE) is -21.89% and return on invested capital (ROIC) is -14.16%.
Return on Equity (ROE) | -21.89% |
Return on Assets (ROA) | -14.03% |
Return on Capital (ROIC) | -14.16% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.22% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +4.22% |
50-Day Moving Average | 50.53 |
200-Day Moving Average | 47.13 |
Relative Strength Index (RSI) | 40.87 |
Average Volume (20 Days) | 654,158 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Senhwa Biosciences had revenue of TWD 1.00 million and -291.54 million in losses. Loss per share was -3.27.
Revenue | 1.00M |
Gross Profit | 548,000 |
Operating Income | -305.70M |
Pretax Income | -290.28M |
Net Income | -291.54M |
EBITDA | -303.65M |
EBIT | -305.70M |
Loss Per Share | -3.27 |
Balance Sheet
The company has 1.17 billion in cash and 19.54 million in debt, giving a net cash position of 1.15 billion or 12.87 per share.
Cash & Cash Equivalents | 1.17B |
Total Debt | 19.54M |
Net Cash | 1.15B |
Net Cash Per Share | 12.87 |
Equity (Book Value) | 1.19B |
Book Value Per Share | 13.31 |
Working Capital | 1.17B |
Cash Flow
In the last 12 months, operating cash flow was -280.10 million and capital expenditures -1.95 million, giving a free cash flow of -282.06 million.
Operating Cash Flow | -280.10M |
Capital Expenditures | -1.95M |
Free Cash Flow | -282.06M |
FCF Per Share | -3.16 |
Margins
Gross Margin | 54.80% |
Operating Margin | -30,570.10% |
Pretax Margin | -29,027.70% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -28,205.70% |
Dividends & Yields
Senhwa Biosciences does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -6.97% |
FCF Yield | -6.74% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |